SCM
VERA icon

Sterling Capital Management’s Vera Therapeutics VERA Stock Holding History

Sterling Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.61K Sell
224
-178
-44% -$6.63K ﹤0.01% 2238
2026
Q1 		$16.2K Buy
402
+39
+11% +$1.68K ﹤0.01% 2118
2025
Q4 		$18.4K Buy
363
+238
+190% +$8.45K ﹤0.01% 2273
2025
Q3 		$3.63K Buy
125
+1
+0.8% +$23 ﹤0.01% 2862
2025
Q2 		$2.92K Buy
124
+74
+148% +$1.66K ﹤0.01% 2795
2025
Q1 		$1.2K Buy
50
+5
+11% +$161 ﹤0.01% 2756
2024
Q4 		$1.9K Buy
45
+5
+13% +$221 ﹤0.01% 2797
2024
Q3 		$1.77K Buy
+40
New +$1.52K ﹤0.01% 2236

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sterling Capital Management's VERA Position: Q2 2026 in Review

Sterling Capital Management reduced its Vera Therapeutics (VERA) stake by 44% in Q2 2026, selling an estimated $6.63K and leaving 224 shares worth $9.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Sterling Capital Management first reported a position in VERA in Q3 2024 and has held it in 8 quarters since. The position peaked at $18.4K in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Sterling Capital Management held 224 shares of Vera Therapeutics worth $9.61K as of Q2 2026.
  • Sterling Capital Management sold 178 Vera Therapeutics shares in Q2 2026, an estimated $6.63K.
  • Vera Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2238 holding.
  • Sterling Capital Management first reported a position in Vera Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Vera Therapeutics position peaked at $18.4K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.